_
Alzheimer's cure: World General Media News Headlines
Alzheimer's treatment: World General Media News Headlines
Alzheimer theories: World General Media News Headlines
Alzheimer science professional news: Alzforum News & Views
July 29, 2005
Vasagen, Another Player of Alzheimer's Disease Biotech Market
"...Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) is focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease. The Company's lead product, the Celacade(TM) technology, is currently in two pivotal phase III clinical trials designed to support regulatory approval in North America and commercialization in North America and Europe. The pivotal phase III SIMPADICO trial, which is fully enrolled at 50 centers in North America, is designed to further investigate the use of Celacade technology to improve intermittent claudication, a debilitating symptom associated with peripheral arterial disease. The pivotal phase III ACCLAIM trial, designed to further investigate the use of Celacade technology to reduce the risk of death and hospitalization in patients with advanced chronic heart failure, is fully enrolled at 176 clinical centers in North America, Europe, and Israel. Vasogen is also developing a new class of drugs for the treatment of neuro-inflammatory disorders, such as Alzheimer's disease. VP025, which has completed phase I clinical development, is the lead product candidate from this new class of drugs..."
For further information: Contact: Glenn Neumann, Investor Relations, 2155 Dunwin Drive, Mississauga, ON, Canada, L5L 4M1, tel: (905) 569-9065, fax: (905) 569-9231, www.vasogen.com, investor@vasogen.com
Source: Vasogen to Present at Adams Harkness' 25th Annual Summer Seminar. Canada NewsWire (press release) - Canada (27 July 2005) [FullText]
For further information: Contact: Glenn Neumann, Investor Relations, 2155 Dunwin Drive, Mississauga, ON, Canada, L5L 4M1, tel: (905) 569-9065, fax: (905) 569-9231, www.vasogen.com, investor@vasogen.com
Source: Vasogen to Present at Adams Harkness' 25th Annual Summer Seminar. Canada NewsWire (press release) - Canada (27 July 2005) [FullText]
posted by Dr. Koudinov @ 29.7.05
Latest PubMed 20 review articles on Alzheimer’s
Latest PubMed 20 research articles on Alzheimer’s amyloid
Latest PubMed 50 research titles on Alzheimer’s
0 Comments:
Post a Comment
<< Home